| Title |
Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities
|
|---|---|
| Published in |
Drugs, November 2018
|
| DOI | 10.1007/s40265-018-1001-8 |
| Pubmed ID | |
| Authors |
Mathew Suji Eapen, Philip M. Hansbro, Anna-Karin Larsson‑Callerfelt, Mohit K. Jolly, Stephen Myers, Pawan Sharma, Bernadette Jones, Md Atiqur Rahman, James Markos, Collin Chia, Josie Larby, Greg Haug, Ashutosh Hardikar, Heinrich C. Weber, George Mabeza, Vinicius Cavalheri, Yet H. Khor, Christine F. McDonald, Sukhwinder Singh Sohal |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 5 | 31% |
| United Kingdom | 1 | 6% |
| India | 1 | 6% |
| United States | 1 | 6% |
| Unknown | 8 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 56% |
| Scientists | 5 | 31% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 100 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 22 | 22% |
| Student > Master | 20 | 20% |
| Student > Ph. D. Student | 7 | 7% |
| Researcher | 6 | 6% |
| Student > Doctoral Student | 4 | 4% |
| Other | 12 | 12% |
| Unknown | 29 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 20% |
| Nursing and Health Professions | 16 | 16% |
| Biochemistry, Genetics and Molecular Biology | 8 | 8% |
| Sports and Recreations | 5 | 5% |
| Psychology | 4 | 4% |
| Other | 14 | 14% |
| Unknown | 33 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#2,872,801
of 25,890,819 outputs
Outputs from Drugs
#371
of 3,487 outputs
Outputs of similar age
#57,919
of 366,459 outputs
Outputs of similar age from Drugs
#8
of 35 outputs
Altmetric has tracked 25,890,819 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,487 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,459 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.